Eugene Medlock
6Patents
3h-index
13Co-inventors
50Inventor score
Filing activity: Mar 16, 2001 → Jan 27, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7611857B2 | IL-receptor like molecules and uses thereof | Emerging Cross-Sectional Technologies | 58 | Expired |
| US7094566B2 | IL-17 receptor like molecules and uses thereof | Emerging Cross-Sectional Technologies | 56 | Expired |
| US7718776B2 | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors | Chemistry; Metallurgy | 23 | Expired |
| US7943738B2 | IL-17 receptor like molecules and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US8455629B2 | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8367063B2 | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.